
What makes lager yeast special? Inside the genetics of beer
While beers such as ales, stouts and sours have their own fanbases, America has long favored a crisp, refreshing lager. But what makes a yeast variety suitable for light, lager beer rather than ales?
According to Chris Todd Hittinger, a professor of genetics evolution at the University of Wisconsin–Madison, Saccharomyces cerevisiae, or baker’s yeast, requires a warm environment for optimal fermentation. This works well for brewing heavier beers, such as ales. However, to produce a lager, brewers need yeast that ferments best at cool temperatures.

Industrial lager brewers favor S. pastorianus, a hybrid of S. cerevisiae and a wild ancestor. Scientists did not understand how S. cerevisiae evolved to give rise to a cold-dwelling species until they discovered the wild ancestor of lager yeast, S. eubayanus, in 2011.
To understand this evolution, Hittinger’s lab compared the genomes of S. cerevisiae and S. eubayanus and found that S. eubayanus acquired cold tolerance in part through its mitochondrial genome.
“When we do experiments where we take a strain of industrial lager yeast, all of which have the S. eubayanus mitochondrial genome, and swap in the S. cerevisiae mitochondrial genome, the temperature preference of the yeast shifts upwards,” Hittinger said. “We think this is one of the big smoking guns, and it explains why all industrial lager strains have an S. eubayanus mitochondrial genome.”

Sugar, sugar, sugar
Beer starts with three main components: hops, yeast and wort — a sugary grain water that contains maltose and maltotriose.
“Unless you like cloyingly sweet beers ... you need to ferment all of the fermentable sugars into carbon dioxide and ethanol to create a nice, crisp, dry lager you’d enjoy on a hot summer day,” Hittinger said.
Domesticated lager yeasts can ferment maltotriose, but S. eubayanus cannot. Hittinger, John Crandall, a Ph.D. student in the Hittinger lab, and collaborators performed adaptive evolution experiments to find out how S. eubayanus could have acquired this trait. They found two distinct mechanisms.

“Both of our studies show that it takes pretty dramatic mutations to evolve this key trait,” Crandall said.
When selecting for maltotriose use, they found S. eubayanus acquired a novel, chimeric maltotriose transporter via genetic recombination of two MALT genes, which alone drive maltose metabolism.
Conversely, when they performed experiments selecting for maltose use, they found that the mutant S. eubayanus changed from diploid to haploid. This change activated an alternative metabolism in the yeast cells, allowing a haploid-specific gene to activate a previously dormant sugar transporter.
“Most of the advantage that haploids have comes from the fact that they express a small set of haploid-specific genes, which defines their cell type,” Crandall said. “None of these (haploid) genes were known to have any regulatory crosstalk with metabolic pathways in Saccharomyces cerevisiae, where that cell type–specification circuit has been extensively studied.”
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in Science
Science highlights or most popular articles

AI in the lab: The power of smarter questions
An assistant professor discusses AI's evolution from a buzzword to a trusted research partner. It helps streamline reviews, troubleshoot code, save time and spark ideas, but its success relies on combining AI with expertise and critical thinking.

Training AI to uncover novel antimicrobials
Antibiotic resistance kills millions, but César de la Fuente’s lab is fighting back. By pairing AI with human insight, researchers are uncovering hidden antimicrobial peptides across the tree of life with a 93% success rate against deadly pathogens.

AI-designed biomarker improves malaria diagnostics
Researchers from the University of Melbourne engineered Plasmodium vivax diagnostic protein with enhanced yield and stability while preserving antibody-binding, paving the way for more reliable malaria testing.

Matrix metalloproteinase inhibitor reduces cancer invasion
Scientists at the Mayo Clinic engineered a TIMP-1 protein variant that selectively inhibits MMP-9 and reduces invasion of triple-negative breast cancer cells, offering a promising tool for targeted cancer research.

Antibiotic sensor directly binds drug in resistant bacteria
Researchers at Drexel University uncover how the vancomycin-resistant bacterial sensor binds to the antibiotic, offering insights to guide inhibitor design that restores antibiotic effectiveness against hospital-acquired infections.

ApoA1 reduce atherosclerotic plaques via cell death pathway
Researchers show that ApoA1, a key HDL protein, helps reduce plaque and necrotic core formation in atherosclerosis by modulating Bim-driven macrophage death. The findings reveal new insights into how ApoA1 protects against heart disease.